Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

104 trials

Showing 20 of 104 results

Testing effectiveness (Phase 2)Looking for participantsNCT06381453
What this trial is testing

Belimumab in Autoimmune Hepatitis

Who this might be right for
Autoimmune Hepatitis
University Health Network, Toronto 48
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Large-scale testing (Phase 3)Study completedNCT00410384
What this trial is testing

Belimumab in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 819
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069051
What this trial is testing

Belimumab in Patients with Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphoid Leukemia in Relapse
University Hospital Tuebingen 120
Not applicableStudy completedNCT05624437
What this trial is testing

BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus

Who this might be right for
SLE (Systemic Lupus)
Centre Hospitalier de Niort 33
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Large-scale testing (Phase 3)UnknownNCT05863936
What this trial is testing

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

Who this might be right for
Lupus NephritisRemissionSafety Issues
Nanjing University School of Medicine 15
Not applicableUnknownNCT03919643
What this trial is testing

BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE

Who this might be right for
Systemic Lupus ErythematosusBAFF Polymorphism
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Post-approval studies (Phase 4)Looking for participantsNCT06411249
What this trial is testing

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 350
Testing effectiveness (Phase 2)Study completedNCT05154734
What this trial is testing

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 14
Post-approval studies (Phase 4)UnknownNCT04447053
What this trial is testing

Sequential Belimumab and T-cell Based Therapy in SLE

Who this might be right for
Systemic Lupus Erythematosus
National University Hospital, Singapore 80
Large-scale testing (Phase 3)UnknownNCT05262686
What this trial is testing

Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00071812
What this trial is testing

A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
Human Genome Sciences Inc. 283
Large-scale testing (Phase 3)Study completedNCT00712933
What this trial is testing

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 738
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Testing effectiveness (Phase 2)WithdrawnNCT01440361
What this trial is testing

Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline
Not applicableNot Yet RecruitingNCT07069972
What this trial is testing

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Yipeng Liu 180
Large-scale testing (Phase 3)Study completedNCT01663623
What this trial is testing

Belimumab in Remission of VASculitis

Who this might be right for
Vasculitis
Human Genome Sciences Inc., a GSK Company 106
Testing effectiveness (Phase 2)UnknownNCT03967925
What this trial is testing

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Who this might be right for
ANCA Associated VasculitisGranulomatosis With Polyangiitis
Rachel Jones 31
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation